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Strategies to Find Candidate Genes  
for Bipolar Disorder 
 
Sir. 
Linkage studies have been revealing many new link-
age loci not supporting previous regions of interest in 
the development of bipolar disorder. In addition, a num-
ber of association studies failed to get continuous repli-
cations as well as family based association studies in bi-
polar disorders.
1 Moreover, 5-HTTLPR and brain-derived 
neurotrophic factor (BDNF) promoter polymorphisms are 
now found to be more complex than previously thought, 
and thus previous papers on these polymorphisms should 
be treated with caution, although some researchers picked 
these genes as relatively most promising candidates for 
bipolar disorder.
1,2 
As proposed before, we could have more well-orga-
nized and robust information by interactive approaches 
combining multiple candidate genes, contributing psy-
chosocial factors and establishment of potential endoph-
enotypes for bipolar disorder. However, these new ap-
proaches would be liable to a repetition of trial and error 
as did past studies since such individual approach has its 
inherent pitfalls (i.e., complexity of polymorphisms, for 
example, 5-HTTLPR was found to have novel alleles 
showing different functional significance; syndromal diag-
nosis of bipolar disorder; presence of small effect genes).
2,3 
Hence we need more clearly-defined new pathway to 
find candidate genes, for example, setup of worldwide co-
operation, consensus and protocols for genetic studies 
which may be lessoned from practical clinical trials, i.e., 
CATIE
4 and EUFEST
5 studies. In fact we may focus on 
more highly selective diseased family data with this ap-
proach, i.e., focusing on single large family excluding geo-
graphic and genetic heterogeneity.   
We may also need to quantify the role of candidate 
genes after complete interactive analyses for their con-
tribution to the disorder and then weighted values should 
be given as their rates of contribution, which eventually 
might give us a statistically stringent model incorporat-
ing proven potential genes (i.e., namely targeted candi-
date gene cluster level I, II and III etc.).  
Other option might be a combination of phylogenetic 
and endophenotypic approach to bipolar disorder since 
the disorder has different clinical and biological faces, 
although currently bipolar disorders are simply catego-
rized as same phenomenological classification and ge-
netic studies are also based on simple diagnostic criteria. 
Finally well-organized and systematized pathway-based 
candidate gene analysis not searching individual gene 
analysis based on specific pathophysiology will also help 
us to shorten finding high risk genes.   
Definitely today is just preparing the first puzzle but 
not finding the final one. I believe that the efficient st-
rategies and tactics to find precise implications through 
stepwise integration of currently available findings are 
more important than finding a new candidate gene today. 
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